Underpin your clinical trials with our R&D intelligence
Maximize your trial’s chances of success with best-in-class clinical trial data and benchmarks.
An effective clinical drug development program strategy requires optimal trial protocol development, operations planning and execution and a clear understanding of the clinical trial landscape. To support success and understand the competition, you need access to relevant, timely clinical trial data and trial benchmarks.
You also need to know where you can find reliable details of competitor and comparator trials as well as information on investigators and sites.
How we can help
It can be very time-consuming to source, review, and analyze available clinical trial data. Parsing through large amounts of information to find the relevant and key insights can also be a frustrating task.
Our easy-to-use products help you quickly filter thousands of trials to find the most relevant set to inform your trial and program strategy – from protocol design to country and principal investigator selection.
We’ll also help you:
10 Oct 2017
The UK has some of the world’s most exciting science, a supportive business environment, and strong companies led by experienced management teams.
By Doro Shin 09 Aug 2017
Breast cancer trials are making the most use of personalized medicine developments in trials, according to data gathered by Trialtrove.
17 Jul 2017
Using exclusive data from Citeline’s Trialtrove, part of the Informa Pharma Intelligence suite of tools, our analysts will go beyond the numbers and dig into the granular details and their implications.
Topic Clinical trials
29 Jun 2017
We’ve made the valuable and trustworthy content of Sitetrove and Trialtrove even better via the enhanced features of the new platform.
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
Our team is always happy to hear from you. Please call us at:
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now: